Search alternatives:
significant interventions » significant interactions (Expand Search), significant interaction (Expand Search), significant alterations (Expand Search)
interventions based » interventions aimed (Expand Search)
clinical decrease » clinical disease (Expand Search), clinical case (Expand Search), clinical areas (Expand Search)
linear decrease » linear increase (Expand Search)
significant interventions » significant interactions (Expand Search), significant interaction (Expand Search), significant alterations (Expand Search)
interventions based » interventions aimed (Expand Search)
clinical decrease » clinical disease (Expand Search), clinical case (Expand Search), clinical areas (Expand Search)
linear decrease » linear increase (Expand Search)
-
41
-
42
-
43
-
44
-
45
-
46
-
47
-
48
-
49
Summary of post-treatment CAPS score changes from clinical trials with psychotherapies.
Published 2025Subjects: -
50
Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes.
Published 2025Subjects: -
51
Summary of post-treatment disease course measures from clinical trials with psychotherapies.
Published 2025Subjects: -
52
-
53
Baseline clinical characteristics and laboratory data of eligible patients in pre- and post-PBPM.
Published 2023Subjects: -
54
-
55
Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications.
Published 2025Subjects: -
56
Summary of post-treatment disease course measures from off-label medications clinical trials.
Published 2025Subjects: -
57
Post-treatment CAPS score changes from clinical trials with off-label PTSD medications.
Published 2025Subjects: -
58
-
59
-
60